Safety and effectiveness of drug-coated devices in chronic limb-threatening ischaemia: a nationwide analysis
In this national CLTI cohort, drug-coated devices were associated with reduced amputation and mortality. Data from this study suggest that DCBs may offer consistent benefit without increased costs.
Authors
- Siling Li (ORCID: https://orcid.org/0009-0006-7645-0878)
- HYEOK-HEE LEE
- Eric A. Secemsky (ORCID: https://orcid.org/0000-0003-3861-3163)
- Osamu Iida
- Maxime Dubosq-Lebaz
- Christian-Alexander Behrendt
- Yann Gouëffic
- Jonathan Sobocinski
- Joseph M. Kim
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Institut Pasteur de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Hôpital Paris Saint-Joseph (FR)
- Groupe Hospitalier de l'Institut Catholique de Lille (FR)
- Asklepios (DE)
- Deaconess Hospital (US)
Publication Details
- Journal
- EuroIntervention
- Published
- 2026-02-23
- DOI
- https://doi.org/10.4244/eij-d-25-00769
- Citations
- 2
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 78.29